Brian Tiffee Taimur Khan Natasha Brandt Stephen Rogan Brandon Pomerenke Jimmy Williams John Quisenberry Matthew Olszewski.

Slides:



Advertisements
Similar presentations
Ranbaxy Laboratories Limited Differential Pricing & Financing of Essential Drugs Experience with Generic drugs Cecile H Miles Head of Western Europe Division.
Advertisements

Estimated Market Size 2006 (US$M)$503 5-Year CAGR (Taka Base)9.27% 5-Year CAGR (US $ Base)4.50% Bangladesh Pharmaceutical Market.
Alan O’Leary SIPTU National Sector Organiser Pharmaceutical Chemical and Medical Devices A Brief Introduction to the Pharmaceutical & Chemical Sector in.
PARMEE DEDHIA M.Pharm (Clinical Pharmacy), NMIMS
Inherency Patent Law 2/10/2004 Schering v Geneva, 339 F.3d 1373 (Fed Cir 2003)
Big Pharma / THE FACTS New Internationalist 362, November 2003.
 Broad-based health care company that discovers, develops, manufactures, and markets products and services  Abbott's main businesses: ◦ Global pharmaceuticals.
SUCCESS FACTORS IN THE PHARMACEUTICAL MARKETPLACE
Hale & Tempest Trends in the Pharmaceutical Industry and the Potential Impact on Future Innovation and Access to Medicines Dr. Brian W Tempest
The Global Pharmaceutical Industry Timothy F Christian, MD, MPA.
More on Generic Drugs Global Classrooms 2013 Rachel Hunkler.
In the last 5 years, the Russian pharmaceutical market has increased on average by 12% in rubles Source: DSM Group, audit of Russian pharmaceutical market.
Sabena Ahmad Iveta Smincakova Dawn Bradbury. Political:  Lighter Regulatory Controls (1960s)  Tighter Regulatory Controls on Clinical trials (1970s)
Drug Pricing in Canada Victoria Brown, Anureet Sohi, Lisa Weger SPHA 511.
Commercial (Non Government Sponsored) Health Plan Medical Cost and Premium Trends Pharmaceuticals15%14% 12% 11%1.8% Hospital Inpatient Outpatient2515.
Pharmaceuticals before and after TRIPS Sudip Chaudhuri Professor of Economics Indian Institute of Management Calcutta BRICS Workshop, Aalborg February,
CURRENT PHARMACEUTICAL MARKETING STRATEGY M.ABHINANDANA M.PHARM Q.A.
Pharmaceutical Industry Analysis Nature of the industry: Highly defensive and 15% of U.S. population aged over 60→Highly mature. Main forces are the suppliers,
Pharmacology II. The Business of Sick.
Hale & Tempest Trends in the Pharmaceutical Industry and the Potential Impact on Future Innovation and Access to Medicines Dr. Brian W Tempest
Facts and Figures 2008 Medicines and Health Care The Norwegian Association of Pharmaceutical Manufacturers (LMI)
Tracie Butte Matthew Pavelchik Collin Williams University of Phoenix Online BSA 310 DR. Manuel Torres May 12,
The intra and inter-firm geography of EMNCs: India’s pharmaceuticals Rory Horner Clark University Graduate School of Geography Presentation for ‘Emerging.
Chapter 1.3.  Sell 1 group of similar products.  Ex. The protocols for manufacturing recombinant human growth hormone are almost identical to those.
STRATEGIC MANAGEMENT 1 Irina Raynaud Pierre Jean Tessier Nicolas Cabrit Clément Tumoine.
November 2013 This is UTC Building & Industrial Systems.
Restrictions on exports of medicine: irrational public policy, backdoor efforts to marginalize compulsory licensing, or Northern protectionism? James Love.
Hale & Tempest Inhalation Drug Delivery Conference Dr. Brian W Tempest CpHI Ramada Hotel, Berlin, Germany 11 September 2013.
TRIPS plus FTAs Rohit Malpani Oxfam America. Public health consequences of TRIPS plus FTAs Prospective studies on FTAs with TRIPS plus provisions –US.
DAVID HARDING MARCH 12, 2008 DCAT WEEK PERCEPTIONS vs. REALITY Facts and Figures on the Generic Industry.
Healthcare SP-35 Michael Mahaney Tianna Nguyen Edward Poitras Matthew Pry.
Drug Prices in Canada and the US: More Than Meets the Eye? National Academy of Social Insurance Annual Conference Wayne Critchley Executive Director, PMPRB.
U.S. Drug Costs Dropped in 2012, but Rises Loom Katie Thomas The New York Times March 18, 2013
The Pharma Industry Industry sales: $346B with 42% growth during the past five years Future growth: 8-10% growth per year; largest companies to grow more.
 The pharmaceutical industry develops, produces, and markets drugs or pharmaceuticals licensed for use as medications.  Pharmaceutical companies are.
Drug Delivery and Generic Medicine The Challenge ahead; Choose where to play. MENA as an Industry Model Mohammad Refaat Khattab Cairo University; Egypt.
An Alternative to Pharmaceutical Patents Christian Engström Vice Chairman, The Swedish Pirate Party.
Russian Pharma: Road map 21 May 2013 Shulyak Sergey General Director DSM Group.
ERM and the Pharmaceutical Industry. Risk  An innate part of every aspect of life, and the business environment is of no exception  Severity, both in.
The essence of global pharmaceutical marketing. Definitions of marketing ‘Marketing is the management process that identifies, anticipates and satisfies.
R&D Investments in Pharmaceutical Markets Abdulkadir Civan Fatih University.
Team Constellation Warner Chilcott DRAFT COPY.  Pharmaceutical products in women's healthcare & dermatology  Perishable in both the physical and intellectual.
International Trade Dr. David J. Molina Economics 4850/5850.
Quality & Safety of Generic Drugs in the World Market World Bank Conference “Good Intentions – Bad Drugs” March 10, 2005 Washington, D.C. Christine Simmon.
Pfizer Pharmaceuticals Company Matt Allunario Maxime Dutois
1 Industry Study Education Segment Cincinnati Investment Model Club.
Issues related to poor IP protection in EMs: Pharmaceutical Example Rob May Commercial Director, Janssen, EMEA Emerging Markets.
The Role of New Markets Advisors in Healthcare Case Study in Pharma.
India – The Pharma Advantage Dr. Brian W Tempest Chief Mentor & Executive Vice Chairman of the Board Ranbaxy Laboratories Limited, Delhi, India Tokyo –
Global Levofloxacin Industry 2016 Market Research Report
Worldwide Opioids Drugs Market
 Teva Pharmaceuticals Garrett Hoffman. Agenda  Company Overview  Drivers and Trends  Valuation  Recommendation  WOOF Discusion.
Birth of Modern Commercial Agriculture. 2 What’s the deal with Organic? Organic agriculture – food grown w/out the aid of herbicides, pesticides, growth.
MarketsandMarkets Presents Asia-Pacific Crop Protection Chemicals Market Trends and Forecast to 2018
India Pharmaceutical & Healthcare Industry 2H12 Bharat Book Bureau.
Interesting Facts about Pharmaceutical industry
Global Pharmaceutical Packaging Machinery Market Worth 8.71 billion by 2022 Phone No.: +1 (214) id:
Global Active Pharmaceutical Ingredients Market 2017 Analysis, Segmentation, Competitors Analysis, Trends and Forecast by 2022 Phone No.: +1 (214)
Indian API manufacturers are fit for outsourcing Pharma products
Trends in the Pharmaceutical Industry and the Potential Impact on Future Innovation and Access to Medicines Dr. Brian W Tempest Pharmaceuticals.
Alexander McKim Faculty Advisor: Dr. Paul Hinker
Present By:- Company Name: Global Market Forecastes Tel: / Web:
Start Career in Sales & Marketing. Advancement in a Company.
An Increasing Demand for Prescription Drugs Drives Profitability
Global Gas Turbine MRO Market in the Power Industry Report : Trends, Forecast and Competitive Analysis 1.
Nutritional Supplements for Active Adults
Best Social Media Marketing Company
Zinc Stearate Market Report : Trends, Forecast and Competitive Analysis 1.
Fillers in the Global Pharmaceutical Market Report : Trends, Forecast and Competitive Analysis 1.
Presentation transcript:

Brian Tiffee Taimur Khan Natasha Brandt Stephen Rogan Brandon Pomerenke Jimmy Williams John Quisenberry Matthew Olszewski

Originator Chemical Drugs GenericsOTC Drugs Active Pharma Ingredients ExcipientsBiologicalsBiosimiliars The U.S. pharmaceutical industry is defined by the census as companies engaged in researching, developing, manufacturing, and marketing drugs and biologicals for human or veterinary use.

The world’s largest pharmaceutical market. Estimated at $300 billion in 2009 Growth has decreased due to an increase in the number of drugs losing patent protection U.S. generic drug market is estimated at $34 billion (41% of global sales)

CompanyLocationSales (in billions) TevaIsrael$11.03 SandozGermany$8.52 MylanUS$4.99 ActavisSwitzerland$2.52 HospiraUS$2.35 WatsonUS$2.27 SanofiFrance$2.04 GreenstoneUS$1.72 StadaGermany$1.50 Dr Reddy’sIndia$1.16

The Patent Cliff is an event in which a large number of patents lose their protection and become available to Generic Pharmaceuticals. At the end of 2011, roughly 30 billion dollars lost their patent protection. (US) Billions